Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Compass Inc. Class A Common Stock (COMP) vs Nuwellis Inc (NUWE) Price & Performance

Compass Inc. Class A Common StockTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

Compass Inc. Class A Common Stock vs Nuwellis Inc — how do they compare? Compass Inc. Class A Common Stock trades at $9.52 (market cap $7.05B), while Nuwellis Inc trades at $0.68 (market cap $2.20M). The key difference: Compass Inc. Class A Common Stock is far larger — about 3204.5× Nuwellis Inc's market cap, and Compass Inc. Class A Common Stock is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Compass Inc. Class A Common Stock for 0 Days and Nuwellis Inc for 26 Days on average.

COMPNUWE
Market Cap
$7.05B$2.20M
Volume
15,310,192121,544
Sector
Real EstateHealth
52-Week High
$13.58$146.65
52-Week Low
$6.68$0.68
Typical Hold Time
0 Days26 Days
Enterprise Value
$10.47B-$1.52M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Compass Inc. Class A Common Stock

No Aura AI signal available yet.

Nuwellis Inc

NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.

The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

COMP
100% Buy0% Sell
Avg holding period · 0 Days
NUWE
40% Buy60% Sell
Avg holding period · 26 Days

Top news

Latest headlines on both assets

About Compass Inc. Class A Common Stock

Compass is a technology-enabled residential real estate company. Its platform provides agents with tools for customer relationships, marketing, client service, and transactions, alongside brokerage, title, escrow, and mortgage services.

Read more on COMP →

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE →